ArticleMedicina (Kaunas, Lithuania)2022

Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.

Shinobu Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.